Natural killer cell neoplasms

Clinical Lymphoma

Volumn 5, Issue 3, 2004, Pages 197-201

  Tse, Eric ^a   Liang, Raymond H S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CD56; Leukemia; Lymphocytosis

Indexed keywords

ANTHRACYCLINE; CD3 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; T LYMPHOCYTE RECEPTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CELLULAR DISTRIBUTION; CYTOPENIA; DISEASE COURSE; EPSTEIN BARR VIRUS; GASTROINTESTINAL TRACT; GENE REARRANGEMENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LEUKEMIA; LYMPHATIC SYSTEM TUMOR; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; NATURAL KILLER CELL; NOSE CAVITY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS; SKIN METASTASIS; VASCULITIS; WORLD HEALTH ORGANIZATION;

EID: 13644261887     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2004.n.027     Document Type: Article

References (44)

1. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003; 3:413-425.
2. Biron CA, Nguyen KB, Pien GC, et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17:189-220.
3. Kim S, Iizuka K, Aguila HL, et al. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci USA 2000; 97:2731-2736.
4. Diefenbach A, Raulet DH. Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 2003; 15:37-44.
5. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16:359-393.
6. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-244.
7. Lopez-Botet M, Llano M, Ortega M. Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation. Immunol Rev 2001; 181:193-202.
8. Jaffe ES, Harris NL, Stein H, et al. WHO Classification of Tumors, Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001.
9. Lanier LL, Testi R, Bindl J, et al. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989; 169:2233-2238.
10. Mann KP, DeCastro CM, Liu J, et al. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. Am J Clin Pathol 1997; 107:653-660.
11. Chiang AK, Srivastava G, Lau PW, et al. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin. Hum Pathol 1996; 27:701-707.
12. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type In: Jaffe ES, Harris N, Stein H, et al, eds. WHO Classification of Tumuors, Pathology and Genetics of Tumuors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001:204-207.
13. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998; 16:70-77.
14. Kassel SH, Echevarria RA, Guzzo FP. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer 1969; 23:920-935.
15. Takahashi N, Miura I, Chubachi A, et al. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol 2001; 74:303-308.
16. Jaffe ES. Nasal and nasal-type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 1995; 27:581-583.
17. Tsang WY, Chan JK, Yip TT, et al. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum Pathol 1994; 25:758-765.
18. van Gorp J, Brink A, Oudejans JJ, et al. Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas. J Clin Pathol 1996; 49:72-76.
19. Rodriguez J, Romaguera JE, Manning J, et al. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma 2000; 39:139-144.
20. Ribrag V, Ell Hajj M, Janot F, et al. Early locoregional high-dose radio-therapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 2001; 15:1123-1126.
21. Proulx GM, Caudra-Garcia I, Ferry J, et al. Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease. Am J Clin Oncol 2003; 26:6-11.
22. Cheung MM, Chan JK, Lau WH, et al. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54:182-190.
23. Liang R, Chen F, Lee CK, et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 1997; 19:91-93.
24. Sasaki M, Matsue K, Takeuchi M, et al. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation. Int J Hematol 2000; 71:75-78.
25. Takenaka K, Shinagawa K, Maeda Y, et al. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leuk Lymphoma 2001; 42:1297-303.
26. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89:4501-4513.
27. Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001; 19:2179-2188.
28. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003; 97:610-627.
29. Tse E, Yeung CK, Trendell-Smith N, et al. A cutaneous sore with black eschar in a cowhide worker. Lancet 2002; 360:306.
30. Chan JKC, Wong KF, Jaffe ES, et al. Aggressive NK-cell leukaemia In: Jaffe ES, Harris N, Stein H, et al, eds. WHO Classification of Tumors, Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001:198-200.
31. Song SY, Kim WS, Ko YH, et al. Aggressive natural killer cell leukemia: clinical features and treatment outcome. Haematologica 2002; 87:1343-1345.
32. Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol 1990; 75:49-59.
33. Mori N, Yamashita Y, Tsuzuki T, et al. Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology 2000; 37:363-371.
34. Soler J, Bordes R, Ortuno F, et al. Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma. Br J Haematol 1994; 86:659-662.
35. Imashuku S, Hibi S, Todo S, et al. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 1999; 23:569-572.
36. DiGiuseppe JA, Louie DC, Williams JE, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol 1997; 21:1223-1230.
37. Bayerl MG, Rakozy CK, Mohamed AN, et al. Blastic natural killer cell lymphoma/leukemia: a report of seven cases. Am J Clin Pathol 2002; 117:41-50.
38. Jacob MC, Chaperot L, Mossuz P, et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003; 88:941-955.
39. Mukai HY, Kojima H, Suzukawa K, et al. High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma. Leuk Lymphoma 1999; 32:583-588.
40. Okuno SH, Tefferi A, Hanson CA, et al. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Haematol 1996; 93:810-812.
41. Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 1999; 106:960-966.
42. Tefferi A, Li CY, Witzig TE, et al. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994; 84:2721-2725.
43. Ohno Y, Amakawa R, Fukuhara S, et al. Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality. Cancer 1989; 64:63-67.
44. Bible KC, Tefferi A. Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis. Br J Haematol 1996; 93:406-408.